Title | Type | ![]() |
H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | %Female (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
142 | Turkish Journal of Cancer | journal | 0.100 Q4 | 10 | 25 | 82 | 544 | 1 | 82 | 0.02 | 21.76 | 34.34 | ![]() |
141 | Biotherapy | journal | 0.101 Q4 | 8 | 60 | 579 | 1105 | 6 | 576 | 0.01 | 18.42 | 11.82 | ![]() |
140 | Reports of Practical Oncology and Radiotherapy![]() | journal | 0.101 Q4 | 36 | 13 | 37 | 246 | 2 | 34 | 0.05 | 18.92 | 27.45 | ![]() |
139 | Tumor Research | journal | 0.101 Q4 | 3 | 6 | 22 | 98 | 0 | 22 | 0.00 | 16.33 | 11.11 | ![]() |
138 | Annals of Cancer Research and Therapy | journal | 0.104 Q4 | 7 | 0 | 28 | 0 | 1 | 28 | 0.00 | 0.00 | 0.00 | ![]() |
137 | Clinical and Translational Oncology | journal | 0.105 Q4 | 61 | 68 | 56 | 1671 | 8 | 38 | 0.14 | 24.57 | 38.79 | ![]() |
136 | Nowotwory![]() | journal | 0.107 Q4 | 11 | 16 | 47 | 601 | 5 | 47 | 0.08 | 37.56 | 40.48 | ![]() |
135 | Electronic Journal of Oncology | journal | 0.111 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ![]() |
134 | Cancer Forum | journal | 0.113 Q4 | 15 | 31 | 99 | 396 | 7 | 95 | 0.02 | 12.77 | 60.00 | ![]() |
133 | Journal of B.U.ON. | journal | 0.116 Q4 | 37 | 81 | 166 | 1777 | 14 | 156 | 0.08 | 21.94 | 35.06 | ![]() |
132 | Pathogenesis![]() | journal | 0.117 Q4 | 8 | 0 | 13 | 0 | 3 | 13 | 0.23 | 0.00 | 0.00 | ![]() |
131 | Giornale Italiano di Oncologia | journal | 0.121 Q4 | 0 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | ![]() |
130 | National Toxicology Program technical report series | journal | 0.121 | 22 | 7 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | ![]() |
129 | Advances in Oncobiology | book series | 0.124 Q4 | 3 | 0 | 23 | 0 | 2 | 20 | 0.09 | 0.00 | 0.00 | ![]() |
128 | Cancer Research, Therapy and Control | journal | 0.125 Q4 | 13 | 26 | 319 | 802 | 39 | 309 | 0.18 | 30.85 | 31.46 | ![]() |
127 | Japanese Journal of Cancer and Chemotherapy | journal | 0.128 Q4 | 25 | 364 | 1249 | 1651 | 160 | 1249 | 0.12 | 4.54 | 6.95 | ![]() |
126 | International Journal of Pediatric Hematology/Oncology | journal | 0.137 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ![]() |
125 | Journal of Tumor Marker Oncology | journal | 0.141 Q4 | 9 | 17 | 63 | 1418 | 12 | 63 | 0.24 | 83.41 | 46.15 | ![]() |
124 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.158 Q4 | 50 | 23 | 183 | 4580 | 51 | 183 | 0.28 | 199.13 | 0.00 | ![]() |
123 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.162 Q4 | 65 | 46 | 32 | 1290 | 14 | 31 | 0.44 | 28.04 | 27.72 | ![]() |
122 | Clinical Lung Cancer | journal | 0.165 Q4 | 74 | 54 | 39 | 1472 | 8 | 29 | 0.21 | 27.26 | 29.03 | ![]() |
121 | Oncology Research and Treatment | journal | 0.172 Q4 | 55 | 123 | 346 | 3359 | 131 | 302 | 0.35 | 27.31 | 22.66 | ![]() |
120 | Gastric Cancer | journal | 0.173 Q4 | 99 | 37 | 39 | 932 | 15 | 36 | 0.38 | 25.19 | 7.06 | ![]() |
119 | Clinical Breast Cancer | journal | 0.179 Q4 | 80 | 49 | 38 | 1460 | 11 | 36 | 0.29 | 29.80 | 33.65 | ![]() |
118 | Breast Disease | journal | 0.183 Q4 | 36 | 39 | 58 | 1637 | 25 | 50 | 0.62 | 41.97 | 50.67 | ![]() |
117 | Current Problems in Cancer | journal | 0.188 Q4 | 47 | 11 | 41 | 1447 | 21 | 35 | 0.36 | 131.55 | 25.00 | ![]() |
116 | Bulletin du Cancer | journal | 0.191 Q4 | 44 | 189 | 525 | 6208 | 234 | 441 | 0.40 | 32.85 | 34.32 | ![]() |
115 | Gann Monographs on Cancer Research | book series | 0.192 Q4 | 10 | 17 | 63 | 678 | 31 | 61 | 0.57 | 39.88 | 8.70 | ![]() |
114 | Cancer Biochemistry Biophysics | journal | 0.211 Q3 | 16 | 0 | 32 | 0 | 22 | 32 | 0.69 | 0.00 | 0.00 | ![]() |
113 | Breast Cancer Research![]() | journal | 0.226 Q3 | 175 | 106 | 266 | 2203 | 86 | 234 | 0.32 | 20.78 | 39.89 | ![]() |
112 | Journal of Brachytherapy International | journal | 0.228 Q3 | 12 | 33 | 79 | 958 | 28 | 79 | 0.25 | 29.03 | 14.29 | ![]() |
111 | Breast![]() | journal | 0.236 | 98 | 146 | 232 | 3523 | 119 | 212 | 0.39 | 24.13 | 34.21 | ![]() |
110 | Prostate Journal | journal | 0.243 Q3 | 7 | 20 | 56 | 466 | 21 | 56 | 0.38 | 23.30 | 12.96 | ![]() |
109 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.253 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ![]() |
108 | Tumori | journal | 0.254 Q3 | 59 | 312 | 485 | 4761 | 317 | 476 | 0.51 | 15.26 | 32.13 | ![]() |
107 | Neoplasma | journal | 0.260 Q3 | 57 | 86 | 255 | 2702 | 180 | 254 | 0.54 | 31.42 | 45.64 | ![]() |
106 | Cytotherapy | journal | 0.273 Q3 | 105 | 56 | 104 | 1610 | 70 | 91 | 0.67 | 28.75 | 34.67 | ![]() |
105 | Prostate Cancer and Prostatic Diseases | journal | 0.280 Q3 | 78 | 45 | 251 | 1191 | 98 | 226 | 0.35 | 26.47 | 15.27 | ![]() |
104 | Human Cell | journal | 0.311 Q3 | 44 | 33 | 79 | 897 | 65 | 77 | 0.47 | 27.18 | 12.28 | ![]() |
103 | Hematological Oncology | journal | 0.323 Q3 | 54 | 13 | 47 | 591 | 53 | 47 | 1.21 | 45.46 | 33.33 | ![]() |
102 | Journal of Experimental and Clinical Cancer Research![]() | journal | 0.332 Q3 | 120 | 92 | 264 | 2485 | 238 | 258 | 0.93 | 27.01 | 26.46 | ![]() |
101 | Japanese Journal of Clinical Oncology | journal | 0.334 Q3 | 95 | 141 | 458 | 2259 | 331 | 392 | 0.59 | 16.02 | 10.06 | ![]() |
100 | Molecular Imaging and Biology | journal | 0.339 Q3 | 78 | 0 | 132 | 0 | 93 | 132 | 0.64 | 0.00 | 0.00 | ![]() |
99 | Tumor Targeting | journal | 0.357 Q3 | 10 | 0 | 54 | 0 | 62 | 52 | 1.44 | 0.00 | 0.00 | ![]() |
98 | Cancer Treatment and Research | journal | 0.363 Q3 | 65 | 73 | 139 | 7349 | 93 | 139 | 0.75 | 100.67 | 28.80 | ![]() |
97 | Oncology | journal | 0.376 Q3 | 83 | 259 | 916 | 2375 | 893 | 879 | 0.94 | 9.17 | 24.23 | ![]() |
96 | Brain Tumor Pathology | journal | 0.382 Q3 | 45 | 24 | 57 | 30 | 54 | 57 | 0.76 | 1.25 | 7.69 | ![]() |
95 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.412 Q3 | 90 | 138 | 415 | 2943 | 528 | 404 | 1.21 | 21.33 | 21.99 | ![]() |
94 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.415 Q3 | 56 | 84 | 117 | 2594 | 109 | 114 | 0.79 | 30.88 | 42.26 | ![]() |
93 | Pathology and Oncology Research![]() | journal | 0.426 Q3 | 61 | 44 | 148 | 1271 | 153 | 148 | 0.91 | 28.89 | 39.77 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®